Popular Articles

EMEA Grants Clinuvel New Orphan Drug - For Solar Urticaria - Designation
Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) is pleased to announce that afamelanotide, its photoprotective drug, has been granted Orphan Medicinal Product (OMP) designation by the European Medicines Agency (EMEA) for the treatment of Solar Urticaria (SU). The EMEA granted afamelanotide its first OMP designation in March 2008 for the treatment of Erythropoietic Protoporphyria (EPP), Clinuvel"s lead indication currently in Phase III clinical trials.
pharmacy online
Doctor Works To Reduce Cancer Burden In Africa
In 2010, cancer will be the single leading cause of death worldwide, overtaking chronic illnesses such as heart disease and stroke. Already cancer causes more deaths than HIV/AIDS, tuberculosis and malaria combined. Almost three-quarters of new cases will occur in developing countries, with more than a million cases in sub-Saharan Africa by 2020, according to World Health Organization projections.
News of the day
Nation's First Bilateral Hand Transplant Recipient Speaks About Surgery And Progress
Jeff Kepner, the nation"s first bilateral hand transplant recipient, spoke at a news conference today about his surgery and showed the progress he has made since the May 4 procedure. Mr. Kepner, who lost both hands and feet following a bacterial infection in 1999, is the second patient to be treated with the "Pittsburgh Protocol," a new immune modulation therapy that aims to reduce the risk associated with toxic anti-rejection drugs.
Cardiovascular

Surgical Mask And Respirator Use Should Be Encouraged During Swine Flu Outbreak

A new article in the journal Risk Analysis assessed various ways in which aerosol transmission of the flu, a central mode of diffusion which involves breathing droplets in the air, can be reduced. Results show that face protection is a key infection control measure for influenza and can thus affect how people should try to protect themselves from the swine flu. Lawrence M. Wein, Ph.D., and Michael P. Atkinson of Stanford University constructed a mathematical model of aerosol transmission of the flu to explore infection control measures in the home. Their model predicted that the use of face protection including N95 respirators (these fit tight around the face and are often worn by construction workers) and surgical masks (these fit looser around the face and are often worn by dental hygienists) are effective in preventing the flu. The filters in surgical masks keep out 98 percent of the virus. Also, only 30 percent of the benefits of the respirators and masks are achieved if they are used only after an infected person develops symptoms. "Our research aids in the understanding of the efficacy of infection control measures for influenza, and provides a framework about the routes of transmission," the authors conclude. This timely article has the potential to impact current efforts and recommendations to control the so-called swine flu by international, national and local governments in perspective. Lawrence M. Wein is affiliated with Stanford University. Amy Molnar Wiley-Blackwell


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):